Cardiovascular Safety Evaluation of Febuxostat and Allopurinol: Findings from the FDA Adverse Event Reporting System

Background: Febuxostat and allopurinol are the most commonly used uric acid-lowering medications, and their safety is of great concern, especially the cardiovascular adverse reactions associated with febuxostat. We propose to study the cardiovascular toxicity of febuxostat and allopurinol using the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yang, Wu, Bin, Gou, Liangwen, Fang, Zhenwei, Xu, Ting, Zhang, Tiejun, Li, Yuwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531992/
https://www.ncbi.nlm.nih.gov/pubmed/37763029
http://dx.doi.org/10.3390/jcm12186089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531992/
https://www.ncbi.nlm.nih.gov/pubmed/37763029
http://dx.doi.org/10.3390/jcm12186089

Ejemplares similares